We've Got Receipts

    — Topic —

    Biotechnology

    2 receipts tracked • 100% industry hit rate

    — Filed —

    2 receipts on Biotechnology

    Browse all →

    RECEIPT #SCOTT-

    JAN 01, 2024

    Called it.

    PREDICTION BY

    Scott Galloway
    “If 2023 was the year of GPT-4, 2024 will be the year of GLP-1.”

    FOLLOW-UP

    GLP-1 drugs, such as Ozempic, remained a dominant technology and market theme throughout 2024. The CoinGeek article (May 2024) specifically mentions Galloway elaborating on this prediction and its downstream consequences, reinforcing its prominence in the year. Numerous reports indicate GLP-1 drugs were a major disruptive force and topic of discussion in 2024, confirming the prediction's directional accuracy.

    ORIGINAL SOURCE

    medium.com
    BiotechnologyAI

    RECEIPT #SCOTT-

    MAY 01, 2024

    Called it.

    PREDICTION BY

    Scott Galloway
    “Tech of the year will be GLP‑1 (perhaps the most involved and detailed of Galloway’s predictions).”

    FOLLOW-UP

    GLP-1 drugs have had a significant impact on markets, consumer behavior, and brand strategy, validating this prediction.

    ORIGINAL SOURCE

    coingeek.com
    BiotechnologyConsumer BehaviorMarketing